表紙
市場調查報告書

Ticagrelor市場: 市場機會分析及未來預測

Ticagrelor Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

出版商 Coherent Market Insights 商品編碼 817576
出版日期 內容資訊 英文 157 Pages
商品交期: 2-3個工作天內
價格
Back to Top
Ticagrelor市場: 市場機會分析及未來預測 Ticagrelor Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
出版日期: 2019年02月28日內容資訊: 英文 157 Pages
簡介

本報告提供Ticagrelor的世界市場調查,市場概要,各類型、用途、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 與研究的目的其假設

  • 研究目的
  • 假設
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場片段:各含有量
    • 市場片段:各症狀
    • 市場片段:各流通管道
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的開發
  • 開發平台分析
  • 歷史概要
  • 合併和收購
  • 法規方案
  • 波特的五力分析
  • PEST分析

第4章 Ticagrelor市場:各含有量

  • 簡介
  • 60 mg
  • 90 mg

第5章 Ticagrelor市場:各症狀

  • 簡介
  • 急性冠狀動脈症候群
  • 缺血性中風

第6章 Ticagrelor市場:各銷售管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第7章 Ticagrelor市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 中南美
  • 非洲
  • 中東

第8章 競爭環境

  • 熱圖分析
  • 企業簡介
    • C.H. Boehringer Sohn AG & Ko. KG
    • Pfizer Inc.
    • Eli Lilly and Company
    • AstraZeneca plc
    • Natco Pharma Limited
    • ANHUI HAIKANG PHARMACEUTICAL CO., LTD.
    • Avra Laboratories Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd
  • 分析師的意見

第9章 Section

  • 參考文獻
  • 調查方法
  • 關於Coherent Market Insights
目錄

Ticagrelor, a drug commonly used as a platelet aggregation inhibitor, received approval from U.S. Food and Drug Administration (USFDA) in July 2011 and in the European Union by the European Commission in December, 2010. Ticagrelor is used for the prevention of thrombotic events such as stroke or heart attack in people with acute coronary syndrome or myocardial infarction with ST wave elevation.

Market Dynamics

Rising prevalence of cardiovascular diseases is attributed to rising geriatric population and changing lifestyles. According to World Health Organization (WHO), around 17.9 million people every year die due to cardiovascular diseases (CVDs), which is about 31% of all global deaths. This is expected to positively impact growth of the ticagrelor market over the next decade.

Furthermore, in September 2016, WHO launched the Global Hearts Initiative through which WHO is supporting governments around the world to improve efforts on CVD prevention and control. Thus, increasing number of non-government and government initiatives, in order to aid in prevention of CVD is expected to help in propelling growth of the ticagrelor market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the ticagrelor market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global ticagrelor market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Pfizer Inc., Eli Lilly and Company, AstraZeneca plc, Natco Pharma Limited, ANHUI HAIKANG PHARMACEUTICAL CO., LTD., Avra Laboratories Pvt Ltd., and Sun Pharmaceutical Industries Ltd
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global ticagrelor market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for ticagrelor market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Ticagrelor Market, By Strength:
    • 60 mg
    • 90 mg
  • Global Ticagrelor Market, By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
  • Global Ticagrelor Market, By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Ticagrelor Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Pfizer Inc.
    • Eli Lilly and Company
    • AstraZeneca plc
    • Natco Pharma Limited
    • ANHUI HAIKANG PHARMACEUTICAL CO., LTD.
    • Avra Laboratories Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Strength
    • Market Snippet, By Indication
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Pipeline Analysis
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Ticagrelor Market, By Strength, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • 60 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • 90 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Ticagrelor Market, By Indication, 2018- 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Acute Coronary Syndrome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Ischemic Stroke
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Ticagrelor Market, By Distribution Channel, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Ticagrelor Market, By Regions, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Natco Pharma Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • ANHUI HAIKANG PHARMACEUTICAL CO., LTD.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Avra Laboratories Pvt. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Sun Pharmaceutical Industries Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top